Skin exposure promotes a Th2-dependent sensitization
to peanut allergens by Tordesillas, Leticia et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Publications from USDA-ARS / UNL Faculty U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska 
2014 
Skin exposure promotes a Th2-dependent sensitization to peanut 
allergens 
Leticia Tordesillas 
Icahn School of Medicine at Mount Sinai 
Ritobrata Goswami 
Icahn School of Medicine at Mount Sinai 
Sara Benedé 
Spanish National Research Council–Autonomous University of Madrid 
Galina Grishina 
Icahn School of Medicine at Mount Sinai 
David Dunkin 
Icahn School of Medicine at Mount Sinai 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub 
Tordesillas, Leticia; Goswami, Ritobrata; Benedé, Sara; Grishina, Galina; Dunkin, David; Järvinen, Kirsi M.; 
Maleki, Soheila J.; Sampson, Hugh A.; and Berin, M. Cecilia, "Skin exposure promotes a Th2-dependent 
sensitization to peanut allergens" (2014). Publications from USDA-ARS / UNL Faculty. 1601. 
https://digitalcommons.unl.edu/usdaarsfacpub/1601 
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research 
Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in 
Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of 
Nebraska - Lincoln. 
Authors 
Leticia Tordesillas, Ritobrata Goswami, Sara Benedé, Galina Grishina, David Dunkin, Kirsi M. Järvinen, 
Soheila J. Maleki, Hugh A. Sampson, and M. Cecilia Berin 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
usdaarsfacpub/1601 
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
4 9 6 5jci.org   Volume 124   Number 11   November 2014
Introduction
IgE-mediated food allergy affects 6%–8% of children, and 
although allergies to foods such as milk or egg are frequently 
outgrown, allergies to peanut are commonly lifelong and affect 
1%–2% of the population (1). Prevalence of peanut allergy is 
increasing (2), and reactions to peanut can be severe and occur 
at a very low dose. It is difficult to avoid peanut due to many fac-
tors, including cross-contamination during food processing. What 
makes peanut such a potent allergen is not understood, although 
in human in vitro systems it was described that Ara h 1 from pea-
nut could bind to DC-specific ICAM3-grabbing nonintegrin (DC-
SIGN) in a glycosylation-dependent manner, resulting in a modi-
fied DC phenotype and increased capacity for Th2 skewing (3, 4). 
Innate recognition of allergens has been described for other clini-
cally relevant allergens, including dust mite allergens that activate 
epithelial cells and DCs through TLR4 and dectin-1 (5, 6).
The vast majority of first reactions to peanut and tree nuts 
occur on the first known ingestion (7), suggesting that expo-
sure resulting in primary sensitization likely occurred through 
another route. There is mixed evidence about a potential role of 
exposure to peanut in utero or through breast milk (8, 9). House-
hold use of peanut, independent of maternal or infant ingestion 
of peanut, is a risk factor for development of peanut allergy (10). 
Furthermore, peanut antigen is readily detectable in household 
dust (11, 12), indicating that environmental exposure to peanut 
is likely. Studies on peripheral blood from patients with peanut 
allergy demonstrate that peanut-responsive T cells are found 
within the fraction bearing the skin-homing receptor CLA (13), 
providing support for the hypothesis that initial priming may 
have occurred through the skin. Ara h 1–MHC II tetramers iden-
tify CD4+ T cells in peanut-allergic subjects that express high 
levels of CCR4 (14), another skin-homing receptor, suggesting 
that skin exposure may be a highly relevant route of exposure for 
peanut sensitization. It is not clear if this is unique to peanut or 
may be common to all foods.
Previous studies have shown that epicutaneous exposure of 
mice to allergens results in sensitization when skin has been lightly 
damaged through tape stripping and that this is downstream of an 
altered immune milieu in the skin, including elevated TSLP and 
IL-21 (15–17). Tape stripping is a model of excoriation of the skin 
analogous to that observed in atopic dermatitis, a condition that 
is a risk factor for the development of food allergy. Furthermore, 
filaggrin mutations that are associated with defective skin barrier 
also convey increased risk for peanut allergy (18). Although food 
allergy is a common feature in children with atopic skin inflamma-
tion, children with healthy skin also become sensitized to peanut. 
We have shown previously that exposure of mice to milk allergens 
by the epicutaneous route can induce sensitization, but only in the 
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iment, milk allergen α-lactalbumin (ALA) exposure was used as 
a negative control group, and mice exposed to ALA alone did not 
develop ALA-specific IgE and IgG1 responses (data not shown). 
To further explore the relationship between known allergenicity 
and responses in this mouse model, mice were epicutaneously 
exposed to extract from cashew, a tree nut with high allergenicity, 
and green bean, a legume with low allergenicity in humans (Sup-
plemental Figure 2). Mice exposed to cashew without exogenous 
adjuvant developed cashew-specific IgE and IgG1 responses, 
while mice exposed to green bean extract developed IgE and IgG1 
responses only in the presence of exogenous adjuvant (cholera 
toxin). These results suggest that the response of mice to epicuta-
neous food allergen exposure is consistent with the allergenicity 
of these foods in humans.
To determine whether the process of hair removal contributed 
to the sensitization response to peanut, perhaps through emptying of 
the hair follicle that is densely surrounded by DCs (20), the experi-
ment was repeated by applying peanut extract to the ear, without any 
pretreatment of the skin. Exposure of mice to peanut extract topically 
on the ear induced peanut-specific IgE and IgG1 responses, basophil 
activation after in vitro allergen stimulation, and anaphylaxis in mice 
when rechallenged (Supplemental Figure 3). Altogether, these results 
show that peanut, similar to cashew and unlike weak allergens such 
as soy, green bean, or milk ALA, is capable of inducing adjuvant-inde-
pendent sensitization by topical exposure on healthy skin.
We next examined which allergens were recognized in mice 
sensitized by the epicutaneous route (Supplemental Figure 4B) 
and compared this to the sensitization profile of peanut-allergic 
subjects (Supplemental Figure 4A). Immunoblotting of peanut 
extract performed with human sera identified 3 bands in the 14- to 
20-kDa range, consistent with Ara h 2 (approximately 17 kDa) and 
Ara h 6 (approximately 14 kDa). These 3 bands were also detect-
able in mice epicutaneously exposed to crude peanut extract 
(CPE). A higher molecular weight band was also detectable in both 
humans and mice, consistent with Ara h 1 (63–68 kDa) or Ara h 
3 (57 kDa). Using purified Ara h 1 and Ara h 2, we examined the 
contribution of these allergens in mice sensitized to CPE. Mice 
exposed to peanut developed detectable IgE antibodies against 
both Ara h 1 and Ara h 2 (Supplemental Figure 4C), and basophil 
activation tests performed with whole blood from peanut-sensi-
tized mice showed a similar threshold of reactivity to the 2 dom-
presence of adjuvant, which was needed to drive dermal DCs to 
the draining lymph node (19). Our previous studies indicate that 
skin exposure is not inherently sensitizing and that some form 
of adjuvant activity is needed to drive sensitization through the 
skin. In this study, we show that peanut can induce sensitization 
when applied to healthy intact skin and that it does so by activating 
innate immunity in the skin, altering the DC phenotype through 
mechanisms mediated by the IL-33 receptor ST2, and driving a 
Th2-polarized T cell response. Our results with peanut allergen 
support the hypothesis that environmental exposure to peanut is 
an important risk factor for sensitization.
Results
Adjuvant-independent sensitization to peanut through epicutaneous 
exposure. We demonstrated previously that mice can be sensitized 
to cow’s milk allergens through the epicutaneous route, but only 
in the presence of exogenous adjuvant (19). To determine whether 
this adjuvant dependence also applies to the potent food allergen 
peanut, we exposed mice to crude protein extracts from peanut. 
Soy extract was used as a comparison extract. The major peanut 
allergens, Ara h 1, Ara h 2, and Ara h 3, are highly homologous to 
proteins found within soy, yet soy allergy is rarely persistent or 
severe. Extracts were applied epicutaneously once per week for 
6 weeks. Briefly, hair was removed with depilatory cream, but no 
tape stripping was performed and antigen was added topically 
in PBS without occlusive bandages. Histology of the skin after 
hair removal confirmed that the stratum corneum was intact 
(data not shown). Mice were then rechallenged and monitored 
for a drop in body temperature indicative of anaphylaxis. Mice 
exposed to peanut extract developed robust peanut-specific IgE 
and IgG1 responses and, when challenged by the intraperitoneal 
route with 100 μg peanut extract, developed severe anaphylaxis 
(Figure 1). In contrast, mice exposed to soy extract generated 
no soy-specific antibodies and did not develop anaphylaxis on 
soy challenge. However, when mice were exposed to soy in the 
presence of the superantigen staphylococcal enterotoxin B (SEB), 
they developed IgE and IgG1 antibody responses to soy (Supple-
mental Figure 1; supplemental material available online with this 
article; doi:10.1172/JCI75660DS1). SEB did not further amplify 
the IgE and IgG1 response to peanut but increased the low 
IgG2a response observed with peanut alone. In the same exper-
Figure 1. Adjuvant-independent sensitization to peanut through epicutaneous exposure. Mice were topically exposed to 1 mg CPE or soy extract weekly 
for 6 weeks. Antigen-specific (A) IgE and (B) IgG1 were measured prior to allergen challenge. Black circles represent values in naive mice, and gray rectan-
gles represent mice exposed to the extract. Mice were challenged with 0.1 mg CPE by intraperitoneal challenge. Body temperature prior to challenge and 30 
minutes after the last challenge are shown in C. **P < 0.01.
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did not have detectable levels of ALA-specific IgE and had low levels 
of ALA-specific IgG1 (Figure 2, A and B). Mice exposed to ALA in 
the presence of either SEB as adjuvant or peanut developed a sig-
nificant ALA-specific antibody response, including IgE and IgG1 
antibodies (Figure 2, A and B), and to a lesser extent IgG2a (data 
not shown). To test the functional consequence of bystander sensi-
tization, mice were challenged with ALA by oral gavage (Figure 2C). 
Mice exposed to ALA alone did not undergo anaphylaxis when they 
were orally rechallenged with ALA, but when mice exposed to ALA 
together with either SEB or peanut were orally rechallenged with 
ALA alone, they developed anaphylaxis, as measured by a signifi-
cant drop in body temperature. We then tested whether Ara h 2, the 
dominant allergen in peanut, could induce bystander sensitization. 
Similar to the results with CPE, topical exposure to Ara h 2 resulted 
in bystander sensitization to ALA (Figure 2, D and E) and anaphy-
laxis in mice orally challenged with ALA alone (Figure 2F). These 
data conclusively demonstrate that peanut, and its major allergen 
Ara h 2, have adjuvant activity when applied to the skin.
Peanut induces an innate cytokine response. To determine 
whether peanut can induce innate responses in vivo, peanut 
extract was applied on the ear, followed by harvesting of tissue 
RNA over time (2–24 hours) and assessment of cytokine expres-
sion by RT-PCR (Figure 3A). We examined expression of the 
cytokines Il1b, Il6, Il33, Il25, and Tslp. These cytokines were cho-
sen since they can alter the phenotype of resident DCs and drive 
the adaptive immune response away from one of tolerance. We 
observed significant upregulation of Il33 expression and a trend 
of increased expression of Il1b but did not observe upregulation 
of other Th2-promoting cytokines (Il25, Tslp) or proinflammatory 
cytokines. To test whether keratinocytes could directly recog-
nize and respond to peanut exposure, we used primary neonatal 
human keratinocytes (Figure 3B). We examined expression of the 
cytokines IL1A, IL1B, TNFA, IL6, GMCSF, TSLP, IL25, and IL33 
after stimulation with CPE that had been cleaned of endotoxin. 
Of these cytokines, IL6 and IL33 were significantly upregulated by 
exposure of keratinocytes to peanut extract. IL-6 was confirmed 
at the protein level to be released in response to peanut in a dose- 
dependent manner (data not shown). Peanut has been shown pre-
viously to have direct effects on mouse and human DCs (3, 24). 
We stimulated bone marrow–derived DCs with peanut extract and 
assessed phenotype by flow cytometry and real-time PCR. Stimu-
lation of cells with peanut extract did not alter the expression of 
MHC II, Cd80, or Cd86 or significantly change the expression of 
cytokines, including Il1b, Il6, or Il10. However, stimulation with 
peanut extract did induce a significant upregulation of Ox40l (Fig-
ure 3C), a costimulatory molecule that we and others have previ-
ously shown is involved in the induction of Th2 responses after 
oral sensitization using cholera toxin adjuvant (25, 26).
inant allergens (Supplemental Figure 4D). A titrated intraperito-
neal challenge of peanut-sensitized mice demonstrated that both 
Ara h 1 and Ara h 2 could trigger anaphylaxis, beginning at a dose 
of 10 μg, but Ara h 2 induced a stronger anaphylactic reaction than 
Ara h 1 (Supplemental Figure 4E).
To determine whether sensitization could also be established 
using purified allergens on exposure, we exposed mice to peanut 
extract or purified Ara h 1 or Ara h 2 epicutaneously without adju-
vant (Supplemental Figure 5). Mice developed marked antibody 
responses to the peanut components (Supplemental Figure 5A), 
indicating that other components in crude extract are not neces-
sary for sensitization. Despite the induction of antibody responses 
to Ara h 1 and Ara h 2, only mice exposed to Ara h 2 experienced 
significant anaphylactic reactions following intraperitoneal chal-
lenge (Supplemental Figure 5B). Ara h 2 is the component of pea-
nut linked most closely to clinical reactivity in humans (21).
Peanut has adjuvant activity on the skin. Sensitization to anti-
gens after epicutaneous exposure has been shown previously to be 
dependent on additional factors, including skin damage (17), pres-
ence of inflammation (22), or use of exogenous adjuvants such as 
SEB (23) or cholera toxin (19). We hypothesized that peanut could 
be inducing “adjuvant-free” sensitization by providing inherent 
adjuvant activity. To test this, we examined the capacity of peanut 
to induce bystander sensitization to the milk allergen ALA that 
we have previously shown is adjuvant dependent (19). Mice were 
exposed to ALA alone or in the presence of peanut or SEB as pos-
itive control once a week for 6 weeks. Mice exposed to ALA alone 
Figure 2. Peanut and Ara h 2 induce bystander sensitization, demonstrat-
ing adjuvant activity. (A–C) Mice were exposed to 0.1 mg ALA on the ear, 
alone, or in the presence of 10 μg SEB or 1 mg CPE once a week for 6 weeks. 
ALA-specific (A) IgE and (B) IgG1 were measured in serum prior to oral 
challenge with ALA. (C) Body temperature was measured at baseline and 
30 minutes after challenge. n = 5 mice per group. (D–F) The experiment was 
repeated with exposure to ALA in the presence or absence of 0.1 mg purified 
Ara h 2. n = 4 per group. *P < 0.05, **P < 0.01, ***P < 0.001, vs. ALA alone.
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affinity maturation. We hypothesized that peanut or SEB promote 
bystander sensitization or self-sensitization by inducing Th2 and/
or Tfh responses. To test whether there was an induction of Th2 
immunity after sensitization, 4get mice (which have GFP expres-
sion in IL-4–expressing cells) (28) were epicutaneously exposed to 
PBS, SEB, or peanut. One week after exposure, the draining lymph 
nodes were harvested and assessed for GFP. We observed a sig-
nificant increase of GFP-positive CD4+ T cells in the skin-drain-
ing lymph nodes (Figure 5A) in response to either peanut or SEB. 
Induction of reporter activity was restricted to the draining lymph 
nodes and was not observed at distal lymph nodes (the mesen-
teric lymph nodes). GFP reporter activity was observed primar-
ily within the memory T cell population (CD44hiCD4+ cells, data 
not shown). We verified the peanut-dependent induction of Th2 
responses by using IL-13 reporter mice (IL-13eGFP mice) (29). 
An increase in IL-13 reporter activity was also observed in the 
skin-draining lymph nodes after epicutaneous exposure to pea-
nut in total CD4+ and CD44hiCD4+ cells (Supplemental Figure 6 
and data not shown). Induction of memory Th2 cells is therefore a 
common response to exposure to peanut and SEB.
We next wanted to determine whether there was a local 
induction of Tfh cells after epicutaneous exposure to peanut or 
SEB. CXCR5+ICOS+ cells in the CD4+ population were defined 
as the Tfh cell population. Mice exposed to SEB via skin showed 
an increased population of CXCR5+ICOS+ cells in skin-draining 
lymph nodes within both total CD4+ and CD44hi memory popu-
lations (Figure 5B and data not shown). In contrast, mice epicu-
taneously exposed to peanut did not have an expansion of local 
Tfh cells, indicating that SEB induces a broader immune response 
than that generated by peanut. IgE class switching has been 
reported to occur outside of germinal centers (30); however, we 
do not have direct evidence to suggest non-germinal center local-
ization of the peanut-specific IgE response.
DCs from peanut-exposed mice are sufficient to drive Th2 priming. 
To determine whether epicutaneous peanut exposure modifies the 
phenotype of DCs in vivo, resulting in functional consequences 
on T cell priming, we purified DCs from the skin-draining lymph 
nodes of mice 24 hours after epicutaneous exposure to ovalbumin 
(OVA) in the presence or absence of peanut. Purified DCs were 
cocultured with OVA-specific CD4+ T cells from DO11.10 mice 
at a 1:5 ratio for 3 days, followed by restimulation with anti-CD3/
CD28 to maximize cytokine output. Cytokine secretion was mea-
sured by ELISA (Figure 4). DCs harvested from mice epicutane-
ously exposed to OVA in the presence of peanut induced signifi-
cantly greater Th2 (IL-4 and IL-5) responses compared with those 
from mice exposed to OVA alone, while IL-10 was unchanged. 
IL-13, IFN-γ, and IL-17 secretion was elevated but did not reach the 
level of statistical significance. CPE alone was used as a negative 
control (without OVA to activate the OVA-specific T cells), with-
out significant differences with respect to PBS or OVA alone (data 
not shown). These results demonstrate that topical peanut expo-
sure alters the phenotype of skin-draining DCs in vivo, resulting 
in an amplification of adaptive immunity, including an elevated 
Th2 immune response. Interestingly, the DC-driven increase in 
Th2 priming was not observed when we used SEB rather than CPE 
as an adjuvant in this model (data not shown), indicating that the 
mechanism mediating the induction of Th2 responses is different 
depending on the nature of the adjuvant factor.
Induction of Th2 immunity can be driven by peanut or adjuvant, 
but only adjuvant induces T follicular helper cells. The generation of 
IgE antibodies resulting in clinical food allergy could potentially 
be driven by 2 T helper subsets: Th2 cells producing IL-4 and IL-13 
and T follicular helper (Tfh) cells. Tfh cells are a subset of CD4+ 
T cells, which induce immunoglobulin class switching and pro-
mote germinal center reactions (27). These cells also secrete low 
levels of IL-4, which is required for somatic hypermutation and 
Figure 3. Innate response to epicutaneous peanut exposure. (A) Mice were exposed to peanut or PBS as control on the ear, followed by RNA isolation and 
RT-PCR for cytokines. (B) Human keratinocytes or (C) mouse bone marrow DCs were exposed in vitro to CPE or PBS as control. Fold change is shown with respect 
to PBS. Relative expression refers to data normalized to the housekeeping gene. Data are mean ± SEM of a least 3 different experiments. *P < 0.05, **P < 0.01.
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ing lymph nodes but not distal lymph nodes (Figure 7A). ST2 is 
expressed on a number of different cell types, including DCs, T 
cells, and innate lymphoid cells. We hypothesized that IL-33 from 
keratinocytes was modulating the function of DCs. Mice were 
treated with isotype or anti-ST2 antibody prior to epicutaneous 
exposure to OVA with peanut as adjuvant. DCs were then purified 
IL-1, IL-6, and IL-33 link innate and adaptive immunity in the 
skin. We observed that peanut induces an innate cytokine response 
from keratinocytes and alters the phenotype of DCs, contributing 
to altered T cell priming. We sought to establish a link between the 
innate immune response and the adaptive immune response in 
vivo. We first blocked cytokines, specifically IL-6 and IL-1, that we 
had observed were upregulated in keratinocytes 
or skin by peanut exposure. IL-6 was blocked with 
neutralizing anti–IL-6 antibody, while IL-1 sig-
naling was blocked with IL-1 receptor antagonist 
(anakinra). Blockade of IL-6 and IL-1 signaling 
prior to SEB exposure resulted in a significant sup-
pression of IL-4 reporter activity in the skin-drain-
ing lymph nodes but did not influence constitutive 
IL-4 reporter activity in a distal lymph node (Fig-
ure 6A). We also observed attenuated numbers of 
CXCR5+ICOS+ Tfh cells in response to SEB when 
IL-1 and IL-6 signaling was blocked (Figure 6B). 
Blockade of ST2, the receptor for IL-33, also led 
to a significant reduction in IL-4 reporter activity 
in vivo (Figure 6C) and a trend toward a reduced 
number of Tfh cells (Figure 6D).
In contrast to the findings with SEB, blocking 
IL-6 and IL-1 had no effect on peanut-induced 
IL-4 reporter activity in draining lymph nodes 
(Supplemental Figure 7). However, similar to 
that with SEB-induced IL-4 production, neu-
tralizing anti-ST2 antibody administered before 
epicutaneous exposure to peanut significantly 
suppressed IL-4 reporter activity in skin-drain-
Figure 4. Effect of in vivo exposure to CPE on priming by DCs. 
DCs were purified from the skin-draining lymph nodes of BALB/c 
mice epicutaneously exposed to PBS, OVA, or OVA and CPE 
and cocultured with DO11.10 CD4+ T cells for 3 days, followed 
by restimulation with CD3/CD28. Data are mean ± SEM of 7 
independent experiments, with each experiment consisting of 3 
pooled mice per group. *P < 0.05, **P < 0.01.
Figure 5. Effect of CPE or SEB on Th2 and Tfh cells. 
4get mice were epicutaneously exposed to PBS, 
peanut (CPE), or SEB. One week later, skin-draining 
lymph nodes (DLN) and mesenteric lymph nodes 
(MLN) were assessed for (A) IL-4 reporter expression 
or (B) Tfh markers CXCR5 and ICOS. Representative 
plots of IL-4+ or CXCR5+ICOS+ cells of total CD4+ cells in 
skin-draining lymph nodes are shown above summary 
plots of the mean ± SEM number of cells normalized 
per million CD4+ T cells for 3 mice per condition.  
*P < 0.05, **P < 0.01.
The Journal of Clinical Investigation R e s e a R c h  a R t i c l e
4 9 7 0 jci.org   Volume 124   Number 11   November 2014
from the skin-draining lymph nodes and cocultured with DO11.10 
T cells. DCs from peanut-exposed mice induced Th2 priming that 
was significantly reduced in mice treated with anti-ST2 antibody 
(Figure 7B), indicating that ST2 was acting at or above the level of 
the DC, resulting in an altered DC phenotype. We and others have 
shown that cholera toxin–driven sensitization by gastrointestinal 
DCs is dependent on OX40L expression by DCs (25, 26); however, 
blockade of OX40L in the skin DC–T cell cocultures resulted only 
in a minor reduction in Th2 cytokine production (Figure 7C). The 
lack of significant effect of OX40L neutralization in response to 
CPE was also observed using 4get mice in vivo (data not shown). 
Together, these data suggest that a diverse set of sensitizing stimuli 
at the level of the skin can induce Th2-skewed immune responses 
through a ST2-dependent modulation of skin DCs.
Discussion
Peanut is one of the most common foods causing allergic reac-
tions, and peanut allergy is increasing in prevalence in the US (2) 
and the UK (31). Peanut allergy, unlike milk or egg allergy, is com-
monly lifelong and is one of the causes of potentially life-threat-
ening anaphylactic reactions (32, 33). In this report, we identify 
novel innate responses to epicutaneous peanut exposure in vivo 
that contribute to the generation of Th2-biased adaptive responses 
to peanut. Our results point to inherent adjuvant factors in peanut 
combined with a nonoral exposure route as being critical to the 
development of peanut allergy.
Environmental exposure to peanut is a risk factor for the devel-
opment of peanut allergy while early dietary exposure of infants to 
peanut is associated with low prevalence of peanut allergy (10, 34). 
The skin is of particular interest as a route of allergen exposure, since 
infant exposure to peanut oil–containing ointments was found to 
be a risk factor for peanut allergy in the UK (35). Exposure to wheat 
hydrolysates in facial soap has also been reported to be associated 
with self-reported wheat allergy (36). We have previously demon-
strated that sensitization to milk allergens can be induced via mul-
tiple physiological routes in mice, including the epicutaneous route, 
but only in the presence of an exogenous adjuvant (19). These pre-
vious results suggest that skin exposure is not inherently allergenic 
but, given the appropriate immune environment, can result in sen-
sitization. For example, the presence of filaggrin mutations, which 
confer susceptibility to atopic dermatitis, is a risk factor for peanut 
allergy independent of atopic dermatitis (18, 37). This is supported 
by preclinical data showing increased susceptibility to sensitiza-
tion in mice with filaggrin mutations (38). In addition, models of 
skin sensitization to food allergens commonly use tape stripping 
that causes mechanical injury to promote skin inflammation and 
the induction of TSLP and Th2 cytokines that lead to sensitization 
(16, 17, 39, 40). Vitamin D analogs, which upregulate TSLP expres-
sion in the skin, can also induce sensitization to food allergens via 
the skin (22). However, here we show evidence that mice can be 
sensitized to peanut or cashew via intact skin in an adjuvant-inde-
pendent fashion, while soy or green bean extracts, used as control 
legume extracts, do not sensitize. This suggests that while the skin 
is not inherently sensitizing upon antigen exposure, it is permissive 
to sensitization to peanut in the absence of adjuvants, unlike oral 
exposure, which leads to tolerance. This finding supports the clin-
ical observations that exposure to peanut through nonoral routes 
promotes sensitization (10), while early oral exposure is associated 
with lower risk of peanut sensitization (34). Our findings also indi-
cate that this paradigm may not fit all allergens, as it does not apply 
to milk (19). The mechanism by which skin, but not gut, exposure 
to peanut alone can induce sensitization is not clear but may relate 
to features of the resident DCs within each site, such as differential 
expression of innate receptors.
Using a series of in vivo approaches, we demonstrated that 
peanut elicits an innate response after topical application to intact 
skin, followed by an induction of the Th2-priming potential of DCs 
in the draining lymph node, leading to the induction of IL-4– and 
IL-13–expressing CD4+ T cells. Although there was an induction of 
IL-1β and IL-6 from skin and keratinocytes, respectively, and these 
cytokines were required for the induction of Th2 and Tfh responses 
using the adjuvant SEB, we did not find evidence for a role of IL-1β 
and IL-6 signaling in the induction of Th2 responses to peanut. 
In both intact mouse skin and human keratinocytes, there was an 
upregulation of IL-33 in response to peanut exposure. In keratino-
cytes this was a late response (24 hours), occurring after the early 
peak of proinflammatory cytokines (2 hours), suggesting that IL-33 
could be upregulated in response to autocrine signals. Blockade of 
ST2, the IL-33 receptor, led to a significant reduction in Th2 cells 
in response to epicutaneous peanut exposure. There is growing 
evidence for a central role of the IL-1 family member IL-33 or ST2 
in the induction of sensitization at multiple tissue sites. Sensitiza-
tion to dust mite through airway exposure is dependent on ST2 (26, 
41), downstream of the innate recognition of dust mite through a 
TLR4-dependent mechanism (41). Oral sensitization to peanut 
(requiring cholera toxin adjuvant) is also ST2 dependent (26). ST2-
expressing resident eosinophils in the gastrointestinal tract were 
Figure 6. Contribution of IL-1, IL-6, and IL-33 to Th2 and Tfh induction 
by SEB. 4get mice were pretreated with either isotype control or (A and 
B) neutralizing IL-6 antibodies plus IL-1 receptor antagonist or (C and D) 
neutralizing anti-ST2 antibody before epicutaneous exposure to SEB. 
Draining lymph nodes and mesenteric lymph nodes were harvested 1 week 
later. Summary plots of (A and C) IL-4+ cells or (B and D) CXCR5+ICOS+ cells 
per million CD4+ T cells are shown. Data are mean ± SEM of 3 mice per 
condition. *P < 0.05, **P < 0.01.
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recently reported to be essential for this oral sensitization to pea-
nut by driving CD103+ DCs expressing elevated levels of CD86 
and OX40L from the lamina propria to the mesenteric lymph node 
(42). Kobayashi et al. recently showed that airway administration 
of exogenous IL-1β or IL-33 together with OVA or ragweed extract 
could induce IgE production against the allergens (43). Interest-
ingly, IL-1β induced IL-17 production in addition to Th2 cytokines, 
while IL-33 induced a more restricted Th2 cytokine induction. Sim-
ilarly, we observed a broader immunologic impact when mice were 
exposed to SEB, which induced Th2 and Tfh cells via IL-1–, IL-6–, 
and ST2-dependent pathways, compared with that when mice 
were exposed to peanut that induced Th2 cells solely through an 
ST2-dependent pathway. ST2 is found on a number of different cell 
types, including innate lymphoid cells (44), allergic effector cells 
(45, 46), and DCs (47). We did not observe any increase in IL-4 or 
IL-13 reporter activity in non-CD4+ T cells after peanut exposure 
in the draining lymph nodes. Furthermore, purified DCs from pea-
nut-exposed mice were able to induce Th2 responses from naive 
T cells in the absence of any other accessory cells, suggesting 
that DCs are sufficient for the induction of Th2-skewed immune 
responses to epicutaneous peanut exposure, although the finding 
does not necessarily rule out contribution from innate sources of 
Th2 cytokines in vivo. Although TSLP can promote sensitization to 
allergens via the skin (17, 22, 39), neither mouse skin nor human 
keratinocytes upregulated TSLP upon peanut exposure, and sen-
sitization of mice to peanut through the skin was normal in TSLP 
receptor–deficient mice (data not shown). This is consistent with 
our previous findings and those of other groups that primary sensi-
tization and generation of IgE in response to oral sensitization can 
occur through TSLP-independent pathways (26, 48).
Keratinocytes are presumed to be a major source of Th2- 
inducing cytokines, including IL-33, IL-25, and TSLP, and, con-
sistent with a keratinocyte source of IL-33 in our model, we 
observed that IL33 mRNA expression was regulated by peanut 
exposure in human keratinocytes in vitro. The receptor for IL-33 
is expressed by DCs, among many other cell types, and treatment 
of DCs with IL-33 has been shown to upregulate OX40L expres-
sion (49). ST2 may modulate DC function upstream through an 
intermediate cell. As an example, gastrointestinal eosinophils 
express ST2 and are required for oral sensitization to peanut 
through eosinophil peroxidase-dependent modulation of DC 
phenotype (42). Recently, two reports identified a skin-draining 
DC subset as being critical for the induction of Th2 immunity 
(50, 51). The markers CD301b and PD-L2 were identified on 
these Th2-inducing DCs, and this DC subset expressed high lev-
els of the IL-33 receptor ST2 (50). Furthermore, these DCs were 
required for induction of Th2 responses but not Tfh responses. 
In addition to acting on DCs, IL-33 can also be produced by DCs 
and act directly on T cells. IL-33 was recently shown to be regu-
lated by IRF-4 in DCs, and DC-derived IL-33 was necessary for 
the induction of Th2 immunity (52). In a model of bee venom–
induced Th2 immunity, IL-33 was shown to be central to the 
induction of Th2 immunity but via direct actions on T cells rather 
than through actions on a DC subset (53). Our data suggest that 
ST2 is acting at the level of the DC or higher, rather than directly 
on the T cells or through innate lymphoid cells, since neutral-
ization of ST2 in vivo suppressed the ability of DCs to directly 
induce Th2 priming after peanut exposure. ST2 also negatively 
regulates TLR2 signaling (54), suggesting that ST2 blockade may 
have effects beyond neutralization of IL-33 signaling.
Figure 7. Peanut induces Th2 polarization through ST2-mediated effects on skin-draining DCs. 4get mice were pretreated with either isotype control or 
neutralizing ST2 antibodies before epicutaneous exposure to CPE. One week after exposure, draining lymph nodes and mesenteric lymph nodes were har-
vested, and (A) IL-4 reporter activity was quantified. Summary data (mean ± SEM) showing number of cells per million CD4+ T cells are shown. n = 3 mice 
per condition. *P < 0.05. (B) BALB/c mice were pretreated with isotype control or anti-ST2 antibody prior to exposure to PBS or OVA and CPE. DCs from 
skin-draining lymph nodes were cocultured with DO11.10 T cells, and cytokine output was measured. Data are mean ± SEM of 3 independent experiments. 
*P < 0.05, compared with isotype control. (C) DCs from skin-draining lymph nodes were isolated after exposure to OVA and CPE and cocultured with 
DO11.10 T cells in the presence of anti-OX40L or isotype control antibody. Data are mean ± SEM of 4 independent experiments.
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extracts were prepared as described above. ALA and OVA (grade 
V) were purchased from Sigma-Aldrich. Purified Ara h 1 and Ara 
h 2 for in vivo studies and basophil activation tests were prepared 
as previously described (63, 64). Extracts used in cell culture were 
purified from endotoxin using Detoxi-Gel columns (Pierce). SEB 
was from Toxin Technologies. Cholera toxin was from List Biolog-
ical Laboratories.
Mice. C3H/HeJ and BALB/c mice were obtained from National 
Cancer Institute, and C3H/HeOuJ mice were obtained from Jackson 
Laboratories. 4get (28) and DO11.10 mice (Jackson Laboratories) were 
maintained as breeding colonies at Mount Sinai. IL-13eGFP (29) mice 
were originally developed by Andrew McKenzie (MRC Laboratory of 
Molecular Biology, Cambridge, United Kingdom) and provided by 
Paul Bryce (Northwestern University, Chicago, Illinois, USA).
Epicutaneous sensitization of mice. Six- to eight-week-old female 
mice were anesthetized, and abdominal fur was removed with depil-
atory cream (Veet; Reckitt Benckiser), immediately followed by expo-
sure to antigens (1 mg crude extract or 0.1 mg purified antigens) in 
50 to 100 μl PBS spread thinly on the abdominal skin to dry. SEB or 
cholera toxin were applied at a dose of 10 μg. In some experiments, 
antigens were applied to the ear pinnae. Mice were exposed weekly 
for a total of 6 exposures and challenged a minimum of 1 week after 
the last exposure.
Allergen challenge and assessment of anaphylaxis. Mice underwent 
an oral challenge to allergen (50 mg ALA or OVA) and were observed 
for 30 minutes following challenge. Body temperature was measured 
before and 30 minutes after challenge. For extracts, mice were chal-
lenged by intraperitoneal route with 100 μg antigen and followed for a 
further 30 minutes prior to measuring temperature with a rectal ther-
mometer (WPI Instruments).
Cytokine neutralization. During neutralization experiments, mice 
were pretreated with neutralizing anti–IL-6 (0.5 mg) or isotype anti-
body (BioXCell) together with the IL-1 receptor antagonist anakinra 
(0.1 mg per mouse, provided by Raphaela Goldbach-Mansky, NIH, 
Bethesda, Maryland, USA). IL-33 receptor (ST2) was blocked with 
neutralizing anti-ST2 (20 μg) or isotype control antibody (R&D Sys-
tems). Mice were then epicutaneously exposed to OVA and SEB or 
CPE. Mice undergoing IL-6/IL-1 or ST2 neutralization received half 
of the initial antibody amount administered every other day for 7 days. 
OX40L was blocked with anti-OX40L (0.2 mg per mouse) or isotype 
control antibody (R&D Systems) twice in 1 week.
Flow cytometry. One week after epicutaneous exposure mice were 
sacrificed, and cells from skin-draining lymph nodes and mesenteric 
lymph nodes were harvested, washed, and stained with anti-mouse 
CXCR5 (BD Biosciences), anti-mouse CD44 (Biolegend), anti-
mouse CD4 (eBioscience), and anti-mouse ICOS (eBioscience), in 
the presence of FcBlock (eBioscience). Cells were acquired on a BD 
LSR Fortessa cytometer (BD Biosciences). Data were analyzed using 
FlowJo software (TreeStar Inc.).
Skin gene expression. CPE (1 mg) applied on the left ears and right 
ears of mice was used as negative control. Ears were harvested 2, 4, 
and 24 hours after the CPE application. Total RNA was isolated with 
Trizol (Invitrogen, Life Technologies), followed by RNA clean up with 
the RNeasy Mini Kit (Qiagen).
Human keratinocytes. Human epidermal keratinocytes (neona-
tal cells, Invitrogen, Life Technologies) were cultured using EpiLife 
medium with growth supplements (all from Gibco, Life Technologies). 
We and others have shown that OX40L on DCs is responsible 
for DC-mediated Th2 skewing and sensitization in the gastroin-
testinal tract (25, 26, 55). In the current studies, OX40L neutraliza-
tion had only a minor inhibitory effect on DC-driven Th2 cytokine 
production in vitro and in vivo, indicating that other mechanisms 
for DC-driven Th2 priming must predominate in the skin.
Our data contributes to the growing body of literature showing 
that allergens activate innate immunity. Allergy to house dust mite 
is one of the most common allergic responses worldwide (56). In the 
case of house dust mite, there are several allergens that have pro-
tease activity (Der p 1, Der p 3, Der p 6, Der p 9) and a capacity to 
bind to lipids (Der p 2) (6, 57, 58). Der p 2 activates the TLR4 signal-
ing pathway by acting as a MD2 mimetic and induces sensitization 
in a TLR4-dependent manner that is dependent on presence of LPS 
within the preparation (5). In pollens, the presence of pollen-associ-
ated lipid mediators that promote Th2 responses has been described 
(59). Lectins derived from legumes are able to activate basophils to 
release IL-4 and IL-13 (60). Peanut has innate activity on human 
DCs, in part through Ara h 1 binding to DC-SIGN (3). Peanut can also 
activate complement that may influence adaptive immune responses 
(61). We found that purified Ara h 2 was sufficient to induce IgE pro-
duction in mice, leading to anaphylaxis upon challenge, and could 
induce bystander sensitization, demonstrating inherent adjuvant 
activity. Ara h 2 is the dominant allergen in peanut, and component 
testing has indicated that IgE against Ara h 2 is predictive of clinical 
reactivity in patients (21). Interestingly, we did not observe innate 
effects of Ara h 2 on human keratinocytes (data not shown), and, 
unlike Ara h 1, Ara h 2 is not significantly glycosylated. Innate effects 
of peanut extract on human DCs were previously shown to be glyco-
sylation dependent, and purified Ara h 2 did not induce a Th2-skew-
ing phenotype in human DCs (3). Thus, the molecular mechanism 
by which Ara h 2 may induce bystander sensitization is unclear. It 
was shown, using timothy grass extract, that Th2-inducing activity 
could be discriminated from IgE binding, and several novel proteins 
were identified that were capable of Th2-inducing activity but were 
not recognized by IgE (62). Similar approaches are needed to iden-
tify all potential T cell modulatory fractions of peanut that may be 
distinct from the dominant allergens.
In summary, we have shown that the skin is permissive to aller-
gic sensitization on exposure to peanut without additional adjuvants 
or tissue damage and that peanut induces Th2 skewing through a 
DC-autonomous pathway that is ST2 dependent. We contrast this 
with sensitization induced by the superantigen SEB, which induces 
both Th2 skewing and Tfh induction through IL-1– and IL-6–depen-
dent as well as ST2-dependent pathways. Our data provide a mech-
anistic explanation for the epidemiologic observations that nonoral 
household exposure to peanut is a risk factor for peanut allergy. Fur-
thermore, this model of adjuvant-independent sensitization to pea-
nut provides a clinically relevant model of peanut allergy that can be 
used to dissect the molecular basis of peanut allergenicity.
Methods
Antigens and adjuvants. Defatted CPE was prepared as previously 
described (24). Briefly, roasted peanuts were shelled, ground to a 
paste, defatted with acetone, dried overnight, and then extracted 
with PBS with complete protease inhibitor (Roche). Soy extract was 
prepared from soy flour (Arrowhead Mills). Green bean and cashew 
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tralization, DCs were cocultured with T cells in the presence of anti-
OX40L (10 μg/ml) or isotype control antibody (R&D Systems).
Immunoblotting. CPE (15 μg/cm) was separated on SDS-PAGE 
(NuPage MES, 4% to 12% ZOOM gels, Invitrogen). The protein was 
transferred onto nitrocellulose membranes (Bio-Rad). After blocking, 
membranes were incubated with diluted human sera (1:50), followed 
by detection with mouse Anti-Human IgE-Alkaline Phosphatase 
(Sigma-Aldrich), alkaline phosphatase chemiluminescent substrate 
(CDP-Star, Sigma-Aldrich), and exposure to film (30–90 minutes). 
Alternatively, membranes were incubated with diluted mouse sera 
(1:20), followed by detection with sheep anti-mouse IgE (Binding 
Site), donkey anti-sheep HRP (Binding Site), and HRP substrate (Mil-
lipore). The blot was exposed for 1 to 5 minutes.
Basophil activation tests. Basophil activation tests were per-
formed as previously described (66). Blood was diluted in RPMI and 
incubated at 37°C for 90 minutes with extracts or purified allergen 
at 50 μg/ml except where indicated. Red blood cells were lysed, and 
cells were stained with CD49b and IgE to detect the population of 
basophils, after gating out T and B cells with CD3/CD19 staining. 
CD200R was used as basophil activation marker (all antibodies were 
from eBioscience).
Statistics. Statistical analyses were performed using GraphPad Prism 
software, version 6.0e (GraphPad). Two-tailed Student’s t test or 2-way 
ANOVA followed by Bonferroni analysis were used for determining 
statistical significance (P < 0.05). Results are expressed as mean ± SEM.
Study approval. All animal procedures were approved by the Insti-
tutional Animal Care and Use Committee of the Icahn School of Med-
icine at Mount Sinai. Clinical specimens were provided by the Jaffe 
Food Allergy Resource Initiative. Inform consent was obtained for all 
the studied subjects. All the procedures were approved by the Institu-
tional Review Board at Mount Sinai School of Medicine.
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Cells were seeded in 24-well plates and stimulated with CPE or soy 
extract. Cells were recovered at several time points for RNA isolation 
with the RNeasy Mini Kit (Qiagen).
Bone marrow–derived DCs. Bone marrow cells were collected 
from femurs and cultured for 10 days in RPMI 1640 with l-glutamine 
(Gibco, Life Technologies), supplemented with 10% fetal bovine serum 
(Gemini Bio-products), penicillin/streptomycin (Gibco, Life Tech-
nologies), 50 μM 2-Mercaptoethanol (Sigma-Aldrich), and 20 ng/ml 
GM-CSF (Peprotech). At day 10, bone marrow–derived DCs were col-
lected and resuspended in complete RPMI at a concentration of 5 × 105 
cells per ml. Cells were stimulated for 3 hours with CPE (50 μg/ml), 
followed by RNA isolation with the RNeasy Mini Kit (Qiagen).
Real-time PCR. RT-PCR was performed, starting from 1 μg total 
RNA, using SuperScript II Reverse Transcriptase (Invitrogen, Life 
Technologies). cDNA was amplified using the Power SYBR Green 
PCR Master Mix (Applied Biosystems, Life Technologies) and run on 
an Applied Biosystems 7300 Real-Time Detection System, using the 
following primers: mouse Il6, F, TTCCATCCAGTTGCCTTCTTG; 
R, GGGAGTGGTATCCTCTGTGAAGTC; mouse Il1b (65), F, 
TTGACGGACCCCAAAAGAT; R, GAGCGCTCACGAACAGTTG; 
mouse Il10 (25), F, TGCTATGCTGCCTGCTCTTA; R, TCATTTC-
CGATAAGGCTTGG; mouse Ox40l (25), F, CCCTCCAATCCAAA-
GACTCA; R, ATCCTTCGACCATCGTTCAG; mouse Il33, F, ATC-
GGGTACCAAGCATGAAG; R, GACTTGCAGGACAGGGAGAC; 
mouse Tslp (48), F, GAGAGAAATGACGGTACTCA; R, CTACAGT-
TAGGTTTGCCCTA; mouse Il25, F, TGTTGCATTCTTGGCAAT-
GATC; R, GACTGCAGCCCTCCTGGAT; human IL6, F, AAA-
GAGGCACTGGCAGAAAA; R, CAGGGGTGGTTATTGCATCT; 
human IL33, F, GAGCTAAGGCCACTGAGGAA; R, TGGGCCTTT-
GAAGTTCCATA.
GADPH and β-actin were used as the housekeeping genes. Rel-
ative quantification was performed using the comparative threshold 
cycle method (2–ΔΔCt). The changes in gene expression were calculated 
with respect to the untreated cells. All amplifications were carried out 
in duplicates.
Antigen presentation assay. Antigen presentation assay was per-
formed as previously described (19). BALB/c mice were exposed to 10 mg 
OVA in the presence or absence of 1 mg CPE. After 24 hours, DCs were 
purified from inguinal lymph nodes by using CD11c microbeads (Mil-
tenyi Biotec). DCs were cultured at a ratio of 1:5 with DO11.10 CD4+ 
T cells. After 72 hours, cells were restimulated with anti-CD3/CD28, 
supernatants were harvested, and cytokines were measured by ELISA 
according to manufacturer’s instructions (all from eBioscience).
In neutralization experiments, anti-ST2 was injected prior to 
exposure with OVA and CPE, as described above. For the OX40L neu-
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